Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets.
暂无分享，去创建一个
M. Dhodapkar | D. Hansel | R. Das | S. Koduru | Juan C. Vasquez | Lin Zhang | K. Dhodapkar | Yanhong Deng | D. Cooper | S. Seropian | S. Couto | Yan Ren | Maria Wang | X. Yao | A. Thakurta | M. Breider | K. Sehgal | M. Kocoglu | R. Verma | Yan J Ren | Y. Ren | Xiaopan Yao